|
Market Closed -
Deutsche Boerse AG
08:43:05 2026-09-01 EDT
|
Pre-market 01:30:50 | |||
| 220.40 EUR | +2.08% |
|
218.75 | -0.75% |
| 09-01 | Global pharma companies that have publicly announced Trump drug pricing agreements | RE |
| 09-01 | White House Cuts Deal to Lower Prescription Drug Prices With Nine Companies | MT |
Chart calendar UCB
Upcoming events on UCB
No events available
Past events on UCB
| 2026-07-30 | Earnings release - Q2 2026 | |
| 2026-07-30 | Earnings presentation | 08:00 |
| 2026-06-08 | Analyst/Investor Day | 08:00 |
| 2026-05-20 | Information meeting | |
| 2026-05-07 | Information meeting | |
| 2026-04-30 | Présentation aux Actionnaires / Analystes | 05:00 |
| 2026-04-30 | Annual General Meeting | 05:00 |
| 2026-02-26 | Earnings presentation | 08:00 |
| 2026-02-25 | Earnings release - Annual 2025 | |
| 2026-01-06 | Information meeting |
Past dividends on UCB
| 2026-05-04 | Ex-dividend date - 1.015 EUR | 00:00 |
Annual results
| Fiscal Period | December | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|
|
Net sales Million EUR | Released Forecast Spread | 5 252 5 196 1.07% | 6 152 5 897 4.33% | 7 741 7 653 1.15% | 8 700 | 9 684 | 10 751 |
|
EBITDA Million EUR | Released Forecast Spread | 1 349 1 239 8.92% | 1 476 1 443 2.28% | 2 636 2 412 9.27% | 3 053 | 3 646 | 4 267 |
|
EBIT Million EUR | Released Forecast Spread | 657 607 8.3% | 836 801 4.38% | 2 009 1 805 11.3% | 2 459 | 3 000 | 3 652 |
|
Earnings before Tax (EBT) Million EUR | Released Forecast Spread | 441 445 -0.85% | 1 163 617 88.61% | 1 822 1 522 19.73% | 2 332 | 2 835 | 3 463 |
|
Net income Million EUR | Released Forecast Spread | 343 349 -1.82% | 1 065 608 75.05% | 1 558 1 230 26.69% | 1 933 | 2 327 | 2 816 |
|
EPS EUR | Released Forecast Spread | 1,76 1,87 -5.77% | 5,61 2,85 96.91% | 8,20 6,36 29.02% | 10,0 | 12,1 | 14,7 |
| Announcement Date | 28/02/24 | 27/02/25 | 24/02/26 | - |
Quarterly results
| Fiscal Period | June | 2024 S2 | 2025 S1 | 2025 S2 | 2026 S1 | 2026 S2 |
|---|---|---|---|---|---|---|
|
Net sales Million EUR | Released Forecast Spread | 3 361 2 975 12.97% | 3 487 3 203 8.88% | 4 254 4 195 1.4% | 4 270 4 056 5.27% | 4 386 |
|
EBITDA Million EUR | Released Forecast Spread | 824 814 1.23% | 1 033 949 8.91% | 1 603 1 456 10.09% | 1 736 1 397 24.3% | 1 280 |
|
EBIT Million EUR | Released Forecast Spread | 502 | 720 725 -0.67% | 1 289 1 119 15.17% | 1 424 1 089 30.73% | 1 091 |
|
Earnings before Tax (EBT) Million EUR | Released Forecast Spread | 917 | 1 229 758 62.14% | 1 305 1 079 20.91% | 1 108 | |
|
Net income Million EUR | Released Forecast Spread | 857 | 1 083 809 33.88% | 1 111 902 23.24% | 925 | |
|
EPS EUR | Released Forecast Spread | 4,52 | 5,76 3,19 80.56% | 5,73 4,60 24.7% | 4,42 | |
| Announcement Date | 27/02/25 | 31/07/25 | 24/02/26 | 30/07/26 | - |
| 2026-09-03 | Earnings presentation | 02:00 | |
| 2026-09-03 | Earnings presentation | 03:00 | |
| 2026-09-06 | Extraordinary General Meeting | 22:00 | |
| 2026-09-08 | Extraordinary General Meeting | 02:30 | |
| 2026-09-09 | Ex-dividend date - 1.62 AUD | 00:00 | |
| 2026-09-09 | Extraordinary General Meeting | 03:00 | |
| 2026-09-10 | Extraordinary General Meeting | 02:30 | |
| 2026-09-10 | Extraordinary General Meeting | 02:00 | |
| 2026-09-28 | Extraordinary General Meeting | 02:30 | |
| 2026-09-28 | Extraordinary General Meeting | 01:30 |
Past sector events for UCB
| 2026-09-01 | Earnings presentation | 04:00 | |
| 2026-08-31 | Extraordinary General Meeting | 02:00 | |
| 2026-08-31 | Earnings release - Q2 2026 | ||
| 2026-08-30 | Earnings presentation | 23:00 | |
| 2026-08-30 | Earnings presentation | 21:30 | |
| 2026-08-30 | Board of Directors Meeting | ||
| 2026-08-30 | Earnings release - Q2 2026 | ||
| 2026-08-30 | Earnings release - Q2 2026 | ||
| 2026-08-30 | Board of Directors Meeting | ||
| 2026-08-29 | Earnings release - Q2 2026 |
Quarterly revenue - Rate of surprise
Net sales - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Stocks
- UCB Stock
- UNC Stock
- Calendar UCB
Select your edition
All financial news and data tailored to specific country editions
















